Related Experiment Video
Updated: Jul 5, 2026
05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Positron emission tomography imaging in dementia
K Herholz1, S F Carter, M Jones
1Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK. Karl.Herholz@manchester.ac.uk
The British Journal of Radiology
|May 1, 2008
Summary
Positron emission tomography (PET) using FDG-PET scans can detect changes in brain glucose metabolism. This technique aids in diagnosing Alzheimer's disease (AD) and other dementias by identifying characteristic patterns of reduced metabolism.
Area of Science:
- Neuroimaging
- Nuclear Medicine
- Neurology
Background:
- Positron emission tomography (PET) is a key imaging technique.
- Measuring regional cerebral glucose metabolism (rCMR(glc)) with FDG-PET is standard in oncology and dementia research.
- Characteristic rCMR(glc) reductions in Alzheimer's disease (AD) occur in specific brain regions, sparing others.
Purpose of the Study:
- To review the application of PET imaging in dementia research.
- To highlight the diagnostic and predictive utility of FDG-PET in Alzheimer's disease and mild cognitive impairment (MCI).
- To discuss the role of novel PET tracers in investigating neuroinflammation, amyloid deposition, and neurotransmitter systems in dementia.
Main Methods:
- Utilizes Positron Emission Tomography (PET) with fluorodeoxyglucose (FDG) to measure regional cerebral glucose metabolism (rCMR(glc)).
- Employs advanced PET tracers like (11)C-PK-11195 for neuroinflammation and (11)C-PIB for amyloid deposition.
- Investigates neurotransmitter systems including cholinergic, dopaminergic, and serotonergic pathways.
Main Results:
- FDG-PET identifies characteristic hypometabolism patterns in AD, FTD, and DLB.
- FDG-PET can predict MCI progression to AD.
- Impaired rCMR(glc) may precede clinical symptoms in individuals at genetic risk for AD.
- PET tracers reveal neuroinflammation and amyloid burden in AD and MCI.
Conclusions:
- PET imaging provides crucial insights into brain function in dementia, unavailable through other modalities.
- PET is vital for early and specific diagnosis of dementia syndromes.
- Future PET research with new tracers will advance dementia diagnosis and therapeutic assessment.
Related Concept Videos
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).